Western University

Scholarship@Western
Paediatrics Publications

Paediatrics Department

10-1-2010

Cardiac outcomes after pregnancy in women with congenital
heart disease
Olga H. Balint
University of Toronto

Samuel C. Siu
University of Toronto, samuel.siu@lhsc.on.ca

Jennifer Mason
University of Toronto

Jasmine Grewal
University of Toronto

Rachel Wald
University of Toronto

See next page for additional authors

Follow this and additional works at: https://ir.lib.uwo.ca/paedpub

Citation of this paper:
Balint, Olga H.; Siu, Samuel C.; Mason, Jennifer; Grewal, Jasmine; Wald, Rachel; Oechslin, Erwin N.;
Kovacs, Brigitte; Sermer, Mathew; Colman, Jack M.; and Silversides, Candice K., "Cardiac outcomes after
pregnancy in women with congenital heart disease" (2010). Paediatrics Publications. 1649.
https://ir.lib.uwo.ca/paedpub/1649

Authors
Olga H. Balint, Samuel C. Siu, Jennifer Mason, Jasmine Grewal, Rachel Wald, Erwin N. Oechslin, Brigitte
Kovacs, Mathew Sermer, Jack M. Colman, and Candice K. Silversides

This article is available at Scholarship@Western: https://ir.lib.uwo.ca/paedpub/1649

Congenital heart disease

Olga H Balint,1 Samuel C Siu,1,2 Jennifer Mason,1 Jasmine Grewal,1 Rachel Wald,1
Erwin N Oechslin,1 Brigitte Kovacs,1 Mathew Sermer,1 Jack M Colman,1
Candice K Silversides1
1

University of Toronto
Pregnancy and Heart Disease
Research Program, Mount Sinai
and Toronto General Hospitals,
Toronto, Ontario, Canada
2
Division of Cardiology,
Department of Medicine,
University of Western Ontario
(SCS), Canada
Correspondence to
Candice Silversides, Toronto
General Hospital, 585 University
Avenue, 5N-521, Toronto,
Ontario, M5G 2N2, Canada;
candice.silversides@uhn.on.ca
Received 17 May 2010
Revised 13 July 2010
Accepted 19 July 2010

ABSTRACT
Objective Women with congenital heart disease (CHD)
are at risk for adverse cardiac events during pregnancy;
however, the risk of events late after pregnancy (late
cardiac events; LCE) has not been well studied. A study
was undertaken to examine the frequency and
determinants of LCE in a large cohort of women with
CHD.
Design Baseline characteristics and pregnancy were
prospectively recorded. LCE (>6 months after delivery)
were determined by chart review. Survival analysis was
used to determine the risk factors for LCE.
Setting A tertiary care referral hospital.
Patients The outcomes of 405 pregnancies were
studied (318 women; median follow-up 2.6 years).
Main outcome measures LCE included cardiac death/
arrest, pulmonary oedema, arrhythmia or stroke.
Results LCE occurred after 12% (50/405) of
pregnancies. The 5-year rate of LCE was higher in
women with adverse cardiac events during pregnancy
than in those without (2769% vs 1563%, HR 2.2,
p¼0.02). Women at highest risk for LCE were those with
functional limitations/cyanosis (HR 3.9, 95% CI 1.2 to
13.0), subaortic ventricular dysfunction (HR 3.0, 95% CI
1.4 to 6.6), subpulmonary ventricular dysfunction and/or
significant pulmonary regurgitation (HR 3.2, 95% CI 1.6
to 6.6), left heart obstruction (HR 2.6, 95% CI 1.2 to 5.2)
and cardiac events before or during pregnancy (HR 2.6,
95% CI 1.3 to 4.9). In women with 0, 1 or >1 risk
predictors the 5-year rate of LCE was 762%, 2365%
and 44610%, respectively (p<0.001).
Conclusions In women with CHD, pre-pregnancy
maternal characteristics can help to identify women at
increased risk for LCE. Adverse cardiac events during
pregnancy are important and are associated with an
increased risk of LCE.

The number of women with congenital heart
disease (CHD) continues to increase so that, in the
current era, most women with CHD are of or will
reach reproductive age.1 Pregnancy is associated
with reversible pregnancy-related increase in blood
volume, heart rate and cardiac output2 3 and, in
some instances, these changes can trigger maternal
cardiac
deterioration
during
pregnancy.4e7
Outcomes after pregnancy in women with CHD
are of particular interest because such women have
been exposed to this prolonged haemodynamic
stress. In certain medical conditions, pregnancy is
felt to act as a physiological stress test and
complications during pregnancy identify women at
high risk for late events.8 Preliminary data from
1656

small retrospective cardiac lesion-speciﬁc studies
have suggested that pregnancy may have an
adverse effect on subsequent maternal cardiac
outcomes, perhaps as a result of the haemodynamic
burden on ventricular structure and function
during pregnancy.9e12 A study was therefore
undertaken to examine the frequency and determinants of adverse maternal cardiac events late
after pregnancy in a large cohort of women with
CHD exhibiting a broad spectrum of cardiac
disease.

METHODS
Study population
Consecutive pregnant women with CHD receiving
care or referred for consultation at our centre
between 1995 and 2007 were included, with
prospective collection of baseline data and
outcomes during pregnancy (antepartum, peripartum and postpartum up to 6 months after
delivery). In this prospectively-deﬁned cohort,
cardiac outcomes late after pregnancy (>6 months
after delivery) were determined retrospectively by
chart review and/or contacting referring cardiologists. The following groups were excluded from
determination of late outcomes: (1) women in
whom pregnancies ended before 20 weeks gestation
by miscarriage, termination or fetal death; (2)
women who died during pregnancy; and (3)
women again pregnant within 6 months of
delivery.

Baseline data collection and outcomes during
pregnancy
Baseline cardiac data were collected at the ﬁrst
antepartum visit as previously described4 5 and
included maternal age, nature of cardiac lesions and
prior interventions, parity, comorbid conditions (eg,
hypertension, diabetes mellitus), history of prior
cardiac events (arrhythmia, congestive heart failure,
stroke/transient ischaemic attack), presence of
cyanosis (oxygen saturation <90%), New York
Heart Association (NYHA) functional class, medications and smoking history. Results from 12-lead
ECG and transthoracic echocardiogram performed
during the ﬁrst antenatal visit were recorded. A
comprehensive transthoracic echocardiogram was
performed and was interpreted by an experienced
echocardiographer. Subaortic ventricular systolic
dysfunction was deﬁned as an ejection fraction
<40%.5 13 Subpulmonic ventricular systolic function was assessed visually and abnormal subpulmonic ventricular dysfunction was deﬁned as
Heart 2010;96:1656e1661. doi:10.1136/hrt.2010.202838
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Maternal cardiac outcomes after pregnancy
Adverse maternal cardiac events late after pregnancy (late
cardiac events; LCE) were ascertained by health record review
and through direct contact with referring physicians. Follow-up
was recorded to the ﬁrst LCE after the index pregnancy or until
the last available clinical follow-up. LCE were deﬁned as any of
the following: cardiac death, cardiac arrest, pulmonary oedema
(documented on the chest x-ray or by crackles heard over at least
one-third of the posterior lung ﬁelds), sustained symptomatic
tachyarrhythmia/bradyarrhythmia requiring treatment or
stroke/transient ischaemic attack.
The frequency of cardiac intervention late after pregnancy
was recorded and included cardiac surgery, percutaneous cardiac
intervention, catheter ablation for arrhythmia management or
pacemaker/internal cardioverter deﬁbrillator implantation.
Cardiac interventions were not used as an end point in the
multivariate model.

Data analysis
Data analysis was performed using SPSS for Windows Version
16 (SPSS Inc, Chicago, Illinois, USA). Means and standard
deviations (SD) or median and interquartile range (IQR) were
calculated as appropriate. Categorical data were expressed as
absolute counts and percentages. Survival analysis was used to
determine predictors of LCE. Differences in the rates of LCE
between groups were determined using log rank tests. Univariate predictors of LCE with a p value <0.15 were entered into
a multivariate Cox proportional hazards model. Subpulmonary
ventricular dysfunction and/or signiﬁcant pulmonary regurgitation were combined into one risk predictor as previously
reported.6 Colinearity between variables was examined and,
Heart 2010;96:1656e1661. doi:10.1136/hrt.2010.202838

when possible, a suitable variable was created (ie, adverse
cardiac events before pregnancy was combined with pregnancyrelated adverse events). The proportional hazard assumptions
were conﬁrmed for each of the variables entered into the
multivariate model. The Cox model was conﬁrmed using
a bootstrap analysis. To account for women with more than
one pregnancy, the multivariate analysis was repeated with the
inclusion of a variable created to identify women with multiple
pregnancies to conﬁrm that the results did not
substantially change. A p value <0.05 was considered statistically signiﬁcant.
Based on the results of the multivariate model, each statistically signiﬁcant variable in the model was given a score of one
point and the risk points were summated to create a new risk
score to estimate the risk of LCE.

RESULTS
During the study period 522 pregnancies in women with CHD
were followed at our centre. Of these, 38 pregnancies ended
before 20 weeks gestation, there were 4 cardiac deaths during
pregnancy, 16 women became pregnant again within 6 months
of the index pregnancy and 59 women did not return for followup. The women who did not return for follow-up were similar in
age to the study population (mean age 2866 years) but were
more likely to have uncomplicated congenital cardiac defects
including intracardiac shunts, bicuspid aortic disease or pulmonary stenosis (72% vs 40%).
The ﬁnal study included 405 pregnancies (318 women, mean
maternal age 2865 years, 66% nulliparous). Pregnancy outcomes
in 185 of the 405 pregnancies have been previously reported as
part of a national study.4 Table 1 summarises the maternal
characteristics of the women included in this study and the
differences in baseline characteristics and pregnancy-related events
between women with or without LCE. Table 2 lists the cardiac
diagnosis for the entire cohort. Certain high-risk populations were
under-represented in the study including women with dilated
aortic roots >40 mm (n¼12), women with mechanical heart
valves (n¼6) and women with severe pulmonary hypertension/
Eisenmenger (n¼4). Few women reported being in NYHA functional class >II or had resting cyanosis (n¼10). Subaortic
ventricular dysfunction (n¼37, 9%) was most common in women
with transposition of the great arteries with atrial switch
surgery (n¼22), congenitally corrected transposition of the great
arteries (n¼5) and univentricular hearts (n¼4). Left heart
obstruction (n¼51, 13%) was primarily due to congenital/bicuspid
aortic valve stenosis (n¼35). The majority of women with
subpulmonic ventricular systolic dysfunction and/or pulmonary
regurgitation (n¼53, 13%) had tetralogy of Fallot (n¼37).
PCE occurred in 46 (11%) pregnancies (1 cardiac arrest, 33
arrhythmias, 19 pulmonary oedema and 1 stroke (events not
mutually exclusive)). Twenty-one of 48 women (44%) with
adverse events before pregnancy had a PCE. Of the 357 women
with no adverse events before pregnancy, 25 developed PCE
(16% of whom had a LCE). An increased CARPREG risk score,
originally created to identify the risk of PCE, was also useful in
identifying women with LCE (table 1).

Adverse cardiac events after pregnancy
The median follow-up time was 2.6 years (IQR 1.4e5.2) after
pregnancy. LCE developed after 50/405 pregnancies (12%). Table 2
shows the LCE according to the underlying cardiac lesions.
Three women (0.007%) died after pregnancy, two of whom had
had a PCE. One woman had repaired tetralogy of Fallot with
1657
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moderate or greater hypokinesis. Valvular regurgitation and
obstruction were assessed by validated methods.14 15 Signiﬁcant
valvular regurgitation was deﬁned as moderate or more in
severity. Speciﬁcally, signiﬁcant pulmonary regurgitation was
deﬁned as laminar retrograde diastolic ﬂow in the pulmonary
artery and/or a pressure half time of <100 ms. Left heart
obstruction in native and prosthetic valves was deﬁned as mitral
valve area <2 cm2, aortic valve area <1.5 cm2 or peak left
ventricular outﬂow tract gradient >30 mm Hg, consistent with
previous reports from our group.5
A previously reported maternal cardiac risk index (CARPREG
risk score) was used to predict cardiac complications during
pregnancy. The score was calculated by assigning one point to
each of the following variables: cardiac events prior to pregnancy
(arrhythmia, congestive heart failure or stroke/transient
ischaemic attack), baseline NYHA functional class >II or
cyanosis, systemic ventricular dysfunction and left heart
obstruction. Higher scores are associated with worse outcomes.5
Maternal pregnancy-related adverse cardiac events (pregnancy
cardiac events; PCE) as previously deﬁned were recorded
prospectively and included cardiac death, cardiac arrest,
pulmonary oedema, sustained symptomatic tachyarrhythmia/
bradyarrhythmia requiring treatment and stroke/transient
ischaemic attack.5 Pregnancy-related non-cardiac adverse
outcomes were also prospectively recorded using predeﬁned
criteria. Adverse obstetric events included pre-eclampsia or
postpartum haemorrhage and adverse fetal and/or neonatal
events included premature birth, small-for-gestational-age birth
weight, respiratory distress syndrome, intraventricular haemorrhage and fetal or neonatal death.5 Maternal placenta-related
complications were deﬁned as pre-eclampsia, preterm birth and/
or small-for-gestational-age birth.

Congenital heart disease
Table 1 Baseline characteristics
Cardiac events late after pregnancy

Maternal baseline characteristics
Maternal age (years)
Parity $1
Smoking
Hypertension or diabetes
Adverse cardiac events before pregnancy*
Cardiovascular medications
NYHA functional class >II or resting cyanosis
Baseline echocardiographic characteristics
Subaortic ventricular dysfunction
Left heart obstruction
Subpulmonary ventricular dysfunction and/or pulmonary regurgitation
Mitral and/or aortic regurgitation ($ moderate in severity)
Pulmonary artery systolic pressure >40 mm Hg
Range
CARPREG risk score5
Risk score $1
Pregnancy outcomes
Adverse maternal cardiac event during pregnancy

Present (N[50)

Absent (N[355)

p Value

2966
31 (62)
4 (8)
1 (2)
14 (28)
12 (24)
3 (6)

2865
148 (42)
25 (7)
5 (2)
34 (10)
51 (14)
7 (2)

0.71
0.009
0.77
0.55
0.001
0.10
0.11

11 (22)
10 (20)
12 (24)
2 (4)
8 (16)
7e71

26 (7)
41 (12)
41 (12)
9 (3)
41 (12)
16e51

0.002
0.11
0.02
0.64
0.47

29 (58)

95 (27)

<0.001

10 (20)

36 (10)

0.04

*Adverse cardiac events before or after pregnancy were defined as any of the following: cardiac death, cardiac arrest, pulmonary
oedema, sustained symptomatic tachyarrhythmia and/or bradyarrhythmia requiring treatment, or stroke or transient ischaemic attack.
CARPREG, maternal cardiac risk index; NYHA, New York Heart Association.

severe pulmonary regurgitation and right ventricular systolic
dysfunction. She died of sudden cardiac death 2 years after an
uneventful pregnancy. The second woman had congenitally
corrected transposition of the great arteries and pulmonary
atresia. She had a left ventricle to pulmonary artery homograft
but had residual subaortic ventricular dysfunction and systemic
atrioventricular valve regurgitation. She died 9 years after pregnancy with end-stage heart failure awaiting cardiac transplantation. Her pregnancy was complicated by arrhythmia and
pulmonary oedema. The third women had an unrepaired atrial
septal defect, severe left ventricular dysfunction and WolfParkinson-White syndrome and died 4 years after pregnancy,
presumably secondary to sudden cardiac death. Her pregnancy
was complicated by pulmonary oedema.
The most common LCEs were arrhythmias which occurred in
35 women (14 supraventricular tachycardia, 17 atrial ﬂutter or
ﬁbrillation and 4 ventricular tachycardia). Congestive heart
failure occurred in 15 women. Overall, the 5-year rate of LCEs
was 1663%. The 5-year rates were higher in women with
CARPREG risk scores $1 (n¼124) than in women with risk
scores of 0 (n¼280) (3066% vs 1062%, p<0.001).
Sixty-two pregnancies (15%) were followed by therapeutic
cardiac interventions (median time to therapeutic intervention
2.4 years, IQR 1.3e3.8). Ten women had their therapeutic
procedure relatively early after delivery (7e12 months); however,
only two of these women had PCE. The most common indications for intervention were arrhythmia and/or congestive heart
failure (40%) or deterioration in functional capacity (38%).
Interventions according to cardiac diagnosis are shown in table 2.
Maternal placenta-related problems occurred in 66 pregnancies (17%) and were similar in women who had LCE and those
who did not (25% vs 16%, p¼0.10).

Risk factors for adverse cardiac events after pregnancy
The univariate predictors of LCE are shown in table 3. Subaortic
ventricular dysfunction was more common in women who had
LCE (p¼0.007). While subpulmonary ventricular dysfunction
1658

and/or signiﬁcant pulmonary regurgitation was not associated
with events during pregnancy, it was associated with LCE
(p¼0.002). The CARPREG risk score, originally created to classify PCE, was also useful to assess the LCE with an increased risk
of LCE in women with risk score >1 (HR 3.6, 95% CI 2.0 to 6.2,
p<0.001). The 5-year rates of LCE were signiﬁcantly higher in
women who had PCE than in those who did not (2769% vs
1563%, p¼0.02, ﬁgure 1). Compared with women without PCE,
women with PCE had more than a twofold risk of LCE (HR 2.2,
95% CI 1.1 to 4.4).
Because of the relationship between adverse cardiac events
before pregnancy and PCE, a single variable was created and
entered into the multivariate model. In the multivariate model,
women at highest risk for LCE were those with NYHA class >II
and/or cyanosis (HR 3.9, p¼0.03), subaortic ventricular
dysfunction (HR¼3.0, p¼0.007), subpulmonary ventricular
dysfunction and/or pulmonary regurgitation (HR¼3.2,
p¼0.002), left heart obstruction (HR¼2.6, p¼0.01) and adverse
cardiac events before pregnancy and/or PCE (HR¼2.5, p¼0.006).
The survival analysis was repeated with the inclusion of a variable created to identify women with more than one pregnancy
recorded in the database. This variable was not signiﬁcant in the
ﬁnal model and the predictors of LCE remained unchanged.
A novel risk score was created based on the above risk factors,
and each predictor as described above in the multivariate model
was assigned one point. In women with 0, 1 or >1 risk factors
the 5-year rate of LCEs was 762%, 2365% and 44610%,
respectively (p<0.001, ﬁgure 2).

DISCUSSION
Although late outcomes have been studied in various congenital
cardiac lesions individually, no previous large studies have
speciﬁcally addressed LCE after pregnancy in women of childbearing age with CHD. This group of women is important
because they have been exposed to a prolonged but reversible
cardiovascular stress. In this large study, most women with
CHD did well after pregnancy and mortality was rare. However,
Heart 2010;96:1656e1661. doi:10.1136/hrt.2010.202838
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N (%) of pregnancies
Total number of pregnancies

Congenital heart disease
Table 2

Maternal adverse cardiac events after pregnancy according to cardiac diagnosis
Number of pregnancies

Total
Shunt lesions
Repaired
Unrepaired
Tetralogy of Fallot/DORV repaired
Aortic coarctation
Repaired
Unrepaired
Congenital aortic stenosis
Repaired
Unrepaired
Transposition of great arteries
Pulmonary stenosis
Repaired
Unrepaired
Marfan syndrome
Ebstein anomaly
Repaired
Unrepaired
Atrioventricular septal defect repaired
Other diagnosisy
Repaired
Unrepaired
Hypertrophic cardiomyopathy
Univentricular heart
Congenitally corrected transposition
Cyanotic patients

Cardiac events late after pregnancy*

Cardiac interventions*

50

Types of cardiac events

62

Types of cardiac events

41
46
70

3
5
9

2 Arr, 1 HF
3 Arr, 1 Arr+CD, 1 S
4 Arr, 3 HF, 1 Arr+CA, 1 CD

2
13
12

1 EP, 1 Surg
1 EP, 11 Cath, 1 Surg
12 Surg

50
2

4
0

2 Arr, 2 HF
e

2
1

20
25
33

1
4
7

1 Arr
1 Arr, 3 HF
6 Arr, 1 HF

4
11
5

8
15
16

0
0
0

e
e
e

0
0
2

e
e
2 Surg

2
13
13

0
4
1

e
4 Arr
1 Arr

0
2
2

e
1 EP, 1 Surg
2 Surg

6
10
14
11
6
4

0
1
4
4
1
2

e
1 HF
1 Arr, 2 HF, 1 Arr+HF
4 Arr
1 Arr+HF+CD
2 Arr

0
0
5
0
0
1

2 Surg
1 Cath
4 Surg CD, 1 S
11 Surg
1 EP, 2 Cath, 2 PM/ICD

e
e
1 Cath, 2 PM/ ICD, 1 Surg, 1 HTX
e
e
1 Surg

Adverse cardiac events are not mutually exclusive.
*Adverse events late after pregnancy: cardiac events (Arr, HF, CD, CA, S) and interventions (Surg, Cath, PM/ICD, EP).
yOther diagnosis: congenital mitral valve disease (n¼1); anomalous pulmonary vein drainage (n¼3); dextrocardia (n¼3); sinus of Valsalva aneurysm (n¼2); congenital coronary anomaly
(n¼4); congenital absence of pericardium (n¼1); idiopathic cardiomyopathy and severe pulmonary regurgitation (n¼2).
Arr, arrhythmia; CA, cardiac arrest; Cath, interventional procedure; CD, cardiac death; DORV, double outlet right ventricle; EP, electrophysiology study with ablation; HF, congestive heart failure;
HTX, heart transplant; PM/ICD, device implantation; S, stroke/transient ischaemic attack; Surg, cardiovascular surgery.

approximately 1/10 pregnancies were followed by a LCE, of
which arrhythmias and heart failure were the most common
events. Women with poor baseline functional ability and/or
Table 3

cyanosis, ventricular dysfunction and left ventricular outﬂow
tract obstruction were at highest risk for LCE. There were
common risk factors that predict both the risk of adverse events

Predictors of adverse maternal cardiac events after pregnancy
Univariate analysis

Maternal baseline characteristics
Maternal age (years)
Parity $1
Smoking
Hypertension or diabetes
Adverse cardiac events before pregnancy
Cyanosis
NYHA functional class >II or resting cyanosis
Pregnancy-related outcomes
Pregnancy-related adverse cardiac events
Adverse cardiac events before pregnancy and/or pregnancy-related adverse cardiac events
Baseline echocardiographic characteristics
Subaortic ventricular dysfunction
Subpulmonary ventricular dysfunction and/or significant pulmonary regurgitation
Left heart obstruction
Mitral and/or aortic regurgitation (moderate or greater in severity)
Pulmonary artery systolic pressure >40 mm Hg

Multivariate analysis*

HR (95% CI)

p Value

HR (95% CI)

p Value

1.0
1.7
0.9
1.4
3.5
2.4
4.3

0.56
0.08
0.86
0.74
<0.001
0.24
<0.001

3.9 (1.2 to 13.0)

0.03

0.02
<0.001

2.6 (1.3 to 4.9)

0.005

3.0 (1.4 to 6.6)
3.2 (1.6 to 6.6)
2.6 (1.2 to 5.2)

0.007
0.002
0.01

(0.9
(0.9
(0.3
(0.2
(1.9
(0.6
(2.0

to
to
to
to
to
to
to

1.0)
3.0)
2.5)
10.2)
6.4)
9.8)
0.3)

2.2 (1.1 to 4.4)
3.0 (1.7 to 5.4)
3.1
2.2
1.7
1.4
1.3

(1.6
(1.1
(0.9
(0.3
(0.6

to
to
to
to
to

6.1)
4.2)
3.4)
5.8)
2.8)

0.001
0.02
0.13
0.65
0.32

*Variables entered into the multivariate model included multiparity, NYHA functional class >II or cyanosis, subaortic ventricular dysfunction, subpulmonary ventricular dysfunction and/or
pulmonary regurgitation, left heart obstruction and adverse cardiovascular events before pregnancy or pregnancy-related adverse cardiac events.
A risk score was created based on the significant predictors of adverse maternal cardiac events identified in the multivariate model. Each variable from the multivariate model was assigned one
point and points were summated to create a risk score to estimate the risk of late adverse cardiac events (see Figure 2).
NYHA, New York Heart Association.

Heart 2010;96:1656e1661. doi:10.1136/hrt.2010.202838
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Total
pregnancies (N)
405

Congenital heart disease
Log-Rank p=0.02

20

Adverse Maternal
Cardiac Event
During Pregnancy
27+9%

10

No Adverse Maternal
Cardiac Events
During Pregnancy
15+ 3%

0
0

1

2

3

4

5

Follow Up Duration (years)
N

405

3 54

253

181

13 2

1 01

Figure 1 Incidence of adverse cardiac events late after pregnancy
according to pregnancy-related adverse cardiac events (time 0 ¼ date of
pregnancy). Adverse cardiac events were defined as any of the
following: cardiac death, cardiac arrest, pulmonary oedema, sustained
symptomatic tachyarrhythmia and/or bradyarrhythmia requiring treatment, or stroke or transient ischaemic attack.
during and after pregnancy. Adverse maternal cardiac events
after pregnancy were more common in women who had cardiac
events during pregnancy.
Because of the nature of the underlying cardiac lesions and the
prior catheter and surgical procedures, adults with CHD have
a propensity for arrhythmias and are at risk of developing
ventricular dysfunction. In non-pregnant adult patients with
CHD, arrhythmias and heart failure are common cardiac
complications,1 16 similar to the types of adverse cardiac events
observed in our population. In a number of congenital cardiac
conditions, heart failure and arrhythmias can be inter-related
and arrhythmias, including atrial arrhythmias, can be markers of
important haemodynamic deterioration.17e20 Thus, identifying
women at highest risk is important so that surveillance can be
tailored to the individual.
Risk factors for LCE were similar to those previously identiﬁed
as risk predictors of pregnancy-related adverse events including
functional status and cyanosis,4 5 subaortic or subpulmonary
ventricular dysfunction5 6 and left heart obstruction.5 9 21 22
This ﬁnding suggests a link between the inability of the heart to
adapt to haemodynamic challenges such as pregnancy and worse
50

Log-Rank p<0.001
B y Ri sk S c o r e

Risk score > 1
44+10%

40
30
20

Risk score 1
23+5%

10

Risk Score O
7+2%

0
0

1

2
3
Follow Up Duration (years)

4

5

Figure 2 Incidence of adverse cardiac events late after pregnancy
according to maternal risk score. The risk score for late events was
calculated based on the sum of risk predictors. Each predictor was
assigned one point. Predictors included in the risk score were: New York
Heart Association functional class >II and/or resting cyanosis, subaortic
ventricular dysfunction, subpulmonary ventricular dysfunction and/or
significant pulmonary regurgitation, left heart obstruction and cardiac
events before or during pregnancy. Adverse cardiac events were defined
as any of the following: cardiac death, cardiac arrest, pulmonary
oedema, sustained symptomatic tachyarrhythmia and/or bradyarrhythmia requiring treatment, or stroke or transient ischaemic attack.
1660

late outcomes. An important ﬁnding in our study demonstrated
that, although the identiﬁable cardiovascular changes of pregnancy resolve after delivery, adverse cardiac events that occur
during this haemodynamic stress appear to have importance,
increasing the risk of LCE.
There are a number of mechanisms which may explain this
association between baseline maternal cardiac variables, PCE and
LCE. The haemodynamic load of pregnancy may serve as
a physiological stress test8 and, in women with underlying heart
disease, may unmask limited cardiac reserve. Conceptually, this
may be similar to the observation that women with placental
syndromes during pregnancy are at increased risk of atherosclerotic disease late in life. In these women, pregnancy unmasks
an underlying ‘abnormal metabolic milieu’ that also predisposes
them to pregnancy complications and to atherosclerotic disease
much later after pregnancy.23 24 Alternatively, the prolonged
haemodynamic stress of pregnancy may directly impact cardiac
function. In the normal heart there is an increase in ventricular
wall stress and an associated deterioration in cardiac function
during pregnancy.25 In a similar fashion, increases in wall stress
may impact the structurally abnormal heart and this may result
in similar or even worse deterioration in cardiac function.
Supporting this concept is the ﬁnding, reported by others, that
systemic ventricular function can irreversibly deteriorate after
pregnancy in women with transposition of the great arteries
and Mustard operations.11 In our series, women with either
subaortic or subpulmonic ventricular dysfunction were at
highest risk for LCE. The prolonged volume load on the heart
may also affect the myocardium in a fashion analogous to the
effect of valvular regurgitation, which is recognised to lead over
time to ventricular dilation and dysfunction. In women with
tetralogy of Fallot it has been suggested that pregnancy can
affect right ventricular volumes.10 Volume overload and
myocyte stretch have been shown to be a stimulus for pathophysiological myocardial processes such as apoptosis, ﬁbrosis
and arrhythmogenesis.26 27 Finally, adverse cardiac events
themselves may directly affect the myocardium. Heart failure is
associated with increases in norepinephrine and epinephrine
which have been shown to have direct cardiotoxic effects
including myocyte injury.28 Clinically, it has been shown that
cardiac outcomes are worse in patients with recurrent admissions for heart failure.29 Continuing to clarify how pregnancy
affects the diseased heart is important for risk stratiﬁcation and
to identify potential therapeutic targets.
Our ﬁndings raise a number of important clinical considerations. Before pregnancy, women at high risk for LCE should be
counselled not only about the risks of adverse cardiac events
during pregnancy but also regarding the potential for adverse
cardiac events after pregnancy. The current risk score should be
used in conjunction with known lesion-speciﬁc data on outcomes.
For instance, women with Marfan syndrome and dilated aortic
roots were under-represented in this study but are known to be at
high risk for complications. In these cases, lesion-speciﬁc
outcomes need to be incorporated into counselling. Once women
become pregnant, those at high risk should receive closer surveillance not only during pregnancy but also late after delivery.
Because adverse events during pregnancy are associated with
higher rates of late events, it is important to re-evaluate the
maternal cardiac status of women with PCE more closely after
pregnancy.

Limitations
A selection bias probably exists as a small number of the women
initially enrolled in our prospective study of pregnancy outcomes
Heart 2010;96:1656e1661. doi:10.1136/hrt.2010.202838
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Cardiac Events Late After
Pregnancy (%)

30

Congenital heart disease

CONCLUSION
Women with CHD are at risk of cardiac complications after
pregnancy. The risk of such events can be predicted by identiﬁcation of maternal factors that predict both the risk of adverse
events during and after pregnancy. Adverse cardiac events during
pregnancy are important and women who develop adverse
cardiac events during pregnancy are at increased risk of LCE.
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were not included in this long-term follow-up study because they
did not receive long-term follow-up at our centre. Women not
followed at our centre were more likely to have less complicated
forms of heart disease. This pattern of follow-up reﬂects the
nature of our clinic and the American College of Cardiology/
American Heart Association guidelines for the follow-up in
patients with simple CHD.30 Because of this, our estimate of the
prevalence of late complications would overestimate rates in
cohorts of women with simple CHD only. However, predictors of
late outcomes are not likely to be affected by this selection bias.
Importantly, women with some high-risk lesions such as
Eisenmenger syndrome, Marfan syndrome with dilated aortic
roots or mechanical heart valves were under-represented in this
study. Not only are these lesions less common in general, but
women with high-risk lesions are often advised to avoid pregnancy. The impact of adverse cardiac events during pregnancy
on late outcomes in this high-risk group cannot be determined.
This study did not examine all adverse events associated with
pregnancy or with late outcomes. During and after pregnancy,
some women suffer signiﬁcant functional deterioration without
frank pulmonary oedema or have prolonged hospital admissions.
Thus, there are other morbidities beyond those deﬁned in our
study, and these may be meaningful for the individual patient.
Late outcome data were collected retrospectively and therefore this study is also subject to the inherent limitations of
a retrospective study. Baseline data had been collected prospectively between 1994 and 2007 and therefore newer echocardiographic measures of right ventricular function such as tissue
Doppler were not available.
Although women with adverse events before and during
pregnancy were at higher risk of LCE, this study did not include
a matched control cohort and therefore was not designed to
determine the impact of pregnancy on the natural history of the
cardiac conditions studied.

